drugset / Trial / NCT00785083
A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the effect of FTY720 on the lung function of patients with moderate asthma
Timeline
- Start
- 2008-09
- Primary completion
- 2009-02
- Completion
- —
Publications
- Results Boulton C, David OJ, Meiser K, Schmouder R. Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma. Clin Pharmacol Drug Dev. 2013 Jan;2(1):2-10. doi: 10.1002/cpdd.4. Epub 2013 Mar 4.
- Izquierdo G, O'Connor P, Montalban X, von Rosenstiel P, Cremer M, de Vera A, Sfikas N, Francis G, Radue EW, Kappos L. Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis. Mult Scler. 2014 Jun;20(7):877-81. doi: 10.1177/1352458513513059. Epub 2013 Nov 30.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fingolimod | Small molecule | 0.5 mg | Oral |
| Subject | Fingolimod | Small molecule | 1.25 mg | Oral |
| Subject | Fingolimod | Small molecule | 2.5 mg | Oral |